"PREDICTIVE SIGNIFICANCE OF SERUM INTERLEUKIN-10 FOR ACUTE GRAFT VERSUS HOST DISEASE PRIOR TO ALLOGENEIC BONE MARROW TRASPLANTATION "

"PREDICTIVE SIGNIFICANCE OF SERUM INTERLEUKIN-10 FOR ACUTE GRAFT VERSUS HOST DISEASE PRIOR TO ALLOGENEIC BONE MARROW TRASPLANTATION "

Interleukin-10 (IL-10) is a potent immunosuppressor which inhibits alloantigenic T cell response. IL-10 is also an anti-inflammatory endogenous cytokine. To investigate the predictive significance of endogenous IL-10 for acute graft versus host disease (GVHD) following allogeneic bone marrow transpl...

Full description

Bibliographic Details
Main Authors:	M. Iravani, B. Mohebbi, B. Bahar, K. Alimoghadam, A. Moosavi, S. Najar-Najafi, A. Ardalan A. Ghavamzadeh
Format:	Article
Language:	English
Published:	Tehran University of Medical Sciences 2005-06-01
Series:	Acta Medica Iranica
Subjects:	interleukin-10 graft versus host disease
Online Access:	https://acta.tums.ac.ir/index.php/acta/article/view/2988

Similar Items

Pretransplant Levels of CRP and Interleukin-6 Family Cytokines; Effects on Outcome after Allogeneic Stem Cell Transplantation
by: Tor Henrik Tvedt, et al.
Published: (2016-11-01)

Tumor vaccine strategies after allogeneic T-cell depleted bone marrow transplantation
by: Ferrara James L.M.
Published: (2002-01-01)

Sphingolipid metabolism in T cell responses after allogeneic hematopoietic cell transplantation
by: Linlu Tian, et al.
Published: (2022-08-01)

Impact of total marrow/lymphoid irradiation dose to the intestine on graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for hematologic malignancies
by: Simonetta Saldi, et al.
Published: (2022-12-01)

Treatment of refractory chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with low-dose interleukin-2
by: I. S. Moiseev, et al.
Published: (2015-12-01)

MSCs Become Collagen-Type I Producing Cells with Different Phenotype in Allogeneic and Syngeneic Bone Marrow Transplantation
by: Robert Maximilian Rusch, et al.
Published: (2021-05-01)

Analysis of interleukin-36 expression in tears of allogeneic hematopoietic stem cell transplantation patients and its correlation with the ocular surface microenvironment
by: Yi-Ning Wang, et al.
Published: (2023-07-01)

Anti-monocyte globulin in allogeneic transplantation of hematopoietic stem cells
by: Yu. R. Zalyalov, et al.
Published: (2022-11-01)

Mesenchymal stem cell-derived exosomes can alleviate GVHD and preserve the GVL effect in allogeneic stem cell transplantation animal models
by: Yan Jiang, et al.
Published: (2023-12-01)

Role of interleukin-6 polymorphism in acute graft-versus-host disease risk prediction in allogeneic hematopoietic stem cell transplantation
by: Afshan Noor, et al.
Published: (2022-01-01)

Development of murine model of allogeneic bone marrow transplantation and graft-versus-host disease
by: I. S. Moiseev, et al.
Published: (2016-12-01)

Alterations of Peripheral Blood T Cell Subsets following Donor Lymphocyte Infusion in Patients after Allogeneic Stem Cell Transplantation
by: Ann-Kristin Schmaelter, et al.
Published: (2021-11-01)

Bone Marrow Transplantation in Thalassemia (Part 1)
by: Maryam Zakerinia
Published: (2009-03-01)

Azithromycin for Prevention of Graft-Versus-Host Disease: A Randomized Placebo-Controlled Trial
by: Maryam Barkhordar, et al.
Published: (2018-04-01)

Allogeneic Stem Cell Transplantation with CD34+ Cell Selection
by: Elisa Roldan, et al.
Published: (2019-09-01)

The role of allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia: A review
by: Robert Puckrin, et al.
Published: (2023-01-01)

Natural Killer Cells as Allogeneic Effectors in Adoptive Cancer Immunotherapy
by: Kyle B. Lupo, et al.
Published: (2019-06-01)

Rehabilitation after Allogeneic Haematopoietic Stem Cell Transplantation: A Special Challenge
by: Hartmut Bertz
Published: (2021-12-01)

Advances in Allogeneic Cancer Cell Therapy and Future Perspectives on “Off-the-Shelf” T Cell Therapy Using iPSC Technology and Gene Editing
by: Yoshiki Furukawa, et al.
Published: (2022-01-01)

Targeting Histone Deacetylases to Modulate Graft-Versus-Host Disease and Graft-Versus-Leukemia
by: Sena Kim, et al.
Published: (2020-06-01)

Hyperacute graft-versus-host disease of the skin following allogeneic stem cell transplantation: A paediatric case series
by: Gauri D Mahabal, et al.
Published: (2023-01-01)

Long-term complete remission of early hematological relapse after discontinuation of immunosuppressants following allogeneic transplantation for Sezary syndrome
by: Hiroki Hosoi, et al.
Published: (2018-09-01)

IL-10 mRNA Engineered MSCs Demonstrate Enhanced Anti-Inflammation in an Acute GvHD Model
by: Cuiping Zhang, et al.
Published: (2021-11-01)

Prospective Analysis of Hemorrhagic Cystitis and BK Viremia in Allogeneic Hematopoietic Stem Cell Transplantation
by: Erden Atilla, et al.
Published: (2020-08-01)

EPC infusion ameliorates acute graft-versus-host disease-related endothelial injury after allogeneic bone marrow transplantation
by: Weiwei Wang, et al.
Published: (2022-12-01)

Allogeneic Stem Cell Transplantation in Multiple Myeloma
by: Christine Greil, et al.
Published: (2021-12-01)

Demodicidosis Accompanying Acute Cutaneous Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation
by: Pelin Aytan, et al.
Published: (2018-11-01)

IL-6 Responsiveness of CD4<sup>+</sup> and CD8<sup>+</sup> T Cells after Allogeneic Stem Cell Transplantation Differs between Patients and Is Associated with Previous Acute Graft versus Host Disease and Pretransplant Antithymocyte Globulin Therapy
by: Tor Henrik Anderson Tvedt, et al.
Published: (2022-04-01)

Longitudinal Survival Outcomes in Allogeneic Stem Cell Transplantation: An Institutional Experience
by: Justin Jiang, et al.
Published: (2022-11-01)

Role of the regulatory T cells CD4+CD25+ and mesenchymal marrow stem cells in suppressing a graft versus host reaction
by: I. A. Korsunsky, et al.
Published: (2022-11-01)

Elevated Galectin-3 Plasma Concentrations in Recipients of Allogeneic Hematopoietic Cell Transplantation
by: Zachariah DeFilipp, et al.
Published: (2019-08-01)

Durability of clinical and immunologic responses to extended low-dose interleukin-2 therapy in patients with refractory chronic graft-versus-host disease
by: Veronica Donato, et al.
Published: (2022-09-01)

Perturbations of mesenchymal stromal cells after allogeneic hematopoietic cell transplantation predispose for bone marrow graft-versus-host-disease
by: Thomas Krüger, et al.
Published: (2022-10-01)

Clinical Aspects Of Sclerodermatous Type Graft-Versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation
by: Hatice Şanlı, et al.
Published: (2010-06-01)

Clinical aspects of sclerodermatous type graft-versus-host disease after allogeneic hematopoietic cell transplantation
by: Hatice Şanlı, et al.
Published: (2010-06-01)

Comparison of Post-transplant Cyclophosphamide Containing Immunosuppressive Regimen with Standard Immunosuppressive Regimen in Allogeneic Stem Cell Transplantation from Matched Sibling Donor
by: Osman KARA, et al.
Published: (2021-12-01)

Current status of research and treatment of dry eye associated with chronic ocular graft-versus-host disease
by: Yuan Liang, et al.
Published: (2022-12-01)

Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma; Insights into Its Potential Role in the Era of New Immunotherapeutic and Targeted Therapies: The GETH/GELTAMO Experience
by: Antonio Gutierrez, et al.
Published: (2022-05-01)

Endothelial Dysfunction Syndromes after Allogeneic Stem Cell Transplantation
by: Dionysios Vythoulkas, et al.
Published: (2023-01-01)

Acute Complications of Pediatric Allogeneic Hematopoietic Stem Cell Transplantation and Their Effects on Survival: A Single-Center Experience in Korea
by: Kyoung Min Lee, et al.
Published: (2023-04-01)